Olivier Kosmider
Publications by Year
Research Areas
Ferroptosis and cancer prognosis, Cancer, Lipids, and Metabolism, Acute Myeloid Leukemia Research, RNA modifications and cancer, Otitis Media and Relapsing Polychondritis
Most-Cited Works
- → Mutation in TET2 in Myeloid Cancers(2009)1,725 cited
- → Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19(2020)906 cited
- → Molecular International Prognostic Scoring System for Myelodysplastic Syndromes(2022)765 cited
- → Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes(2020)618 cited
- → Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia(2013)539 cited
- → Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias(2011)464 cited
- → Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*(2021)389 cited
- → Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia(2013)280 cited
- → ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients(2014)274 cited
- → TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)(2009)269 cited